Paul pays tribute to dedication of staff as he prepares to leave Moscow HSCT centre

Although I have taken a break from writing during August, I just had to catch up with Paul Morrison who, earlier this month, travelled to Moscow to undergo HSCT for multiple sclerosis. The exact type of the disease is a matter of opinion, his neurologist says Paul has SPMS, but tests in Moscow indicate a … Continue reading Paul pays tribute to dedication of staff as he prepares to leave Moscow HSCT centre

Charity AIMS to help MS patients to have HSCT

A new multiple sclerosis charity has appeared in the UK, inspired by one successful HSCT treatment, provided free of charge by the country’s National Health Service (NHS). It is the first charity dedicated to autologous hematopoietic stem cell transplantation (HSCT) for MS patients living in the UK. The treatment was given to James Coates two … Continue reading Charity AIMS to help MS patients to have HSCT

#paulsfighttowalk : Support sought for HSCT in Moscow

Former Londoner Paul Morrison is seeking support to travel to Moscow to receive hematopoietic stem cell transplantation (HSCT) in August. These days Paul (46) and his family live a stone’s throw from my home in southern Spain. He shares my challenge of living with multiple sclerosis. His dad, Phil, has set up a GoFundMe account, … Continue reading #paulsfighttowalk : Support sought for HSCT in Moscow

HSCT ‘safe and effective’ for people with relapsing MS, international study

At last, interim results of an international study show haematopoietic stem cell transplantation (HSCT) is an effective and safe treatment. It outperforms disease modifying therapies (DMTs) for people with highly-active relapsing MS. Sadly, though, that’s as far as the study goes. Despite there being numerous people with progressive MS who say they have benefited from … Continue reading HSCT ‘safe and effective’ for people with relapsing MS, international study

Caroline hopes HSCT has halted MS – 12 months on, no new lesions

HSCT is a great treatment for multiple sclerosis but, to be fair, its beneficial effects are not felt by everyone who undergoes the therapy. Autologous hematopoietic stem cell transplantation, to give HSCT its full title, is an intense procedure. It involves harvesting stem cells from each patient, doses of chemotherapy suppress the immune system, before … Continue reading Caroline hopes HSCT has halted MS – 12 months on, no new lesions

Drugs, risks, spending cuts, deaths, new drugs, and so much more

As we reach the start of another year, it seems a good time for me to review the last 12 months, as seen through the eyes of 50shadesofsun.com. January The year began by focusing on hematopoietic stem cell transplantation (HSCT). Dr Denis Fedorenko of the HSCT centre in Moscow published a guide to the procedure. … Continue reading Drugs, risks, spending cuts, deaths, new drugs, and so much more

HSCT is superior to DMTs say Swedish researchers

At last, independent researchers have endorsed autologous hematopoietic stem cell tranplantation (HSCT) as a treatment of choice for multiple sclerosis. Well, treatment for relapsing MS, anyway. The study “Autologous haematopoietic stem cell transplantation for neurological diseases” was published in the Journal of Neurology, Neurosurgery & Psychiatry. In it, Swedish researchers, from Uppsala University, say autologous HSCT … Continue reading HSCT is superior to DMTs say Swedish researchers